Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride
Тип публикации: Journal Article
Дата публикации: 2016-08-31
SCImago Q2
WOS Q2
БС2
SJR: 0.471
CiteScore: 4.7
Impact factor: 2.9
ISSN: 10837450, 10979867
PubMed ID:
27476543
General Medicine
Pharmaceutical Science
Краткое описание
Abstract Eradication of ophthalmic infections depends on increasing transcorneal permeation and localizing antibiotics at ocular surface. This study aimed at formulating lomefloxacin HCl (LF) in the form of niosomes and evaluating the in vivo performance of best formula in rabbits’ eyes. Vesicles were developed by mixing three surfactants at three molar ratios of 1:1, 1:2 and 1:3 of surfactant to cholesterol. Size, zeta potential, release percentage, transcorneal permeation parameters, stability studies, cytotoxicity and antibacterial activity of niosomes were determined. Niosomes showed encapsulation efficiency of more than 78%, particle size below 500 nm and zeta potential below −43.6. The produced vesicles showed significantly higher amounts of drug permeated across cornea (166%) compared to LF solution. The in vivo study showed 2–5 folds increase in drug concentration in ocular fluids and tissues following administration of niosomes compared to marketed formula (from 3.75 to 10.31 mcg/mL in the cornea). Microbiological studies showed 35 folds increase in the antibacterial activity of LF niosomes compared to free drug; where MBC decreased from 31.25 mcg/mL in case of LF solution to 0.97 mcg/mL for niosomal gel. The formulated niosomes enhanced the ocular bioavailability of LF through increasing transcorneal permeation and localizing drug at site of action.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
4
|
|
|
AAPS PharmSciTech
4 публикации, 8.51%
|
|
|
Journal of Drug Delivery Science and Technology
4 публикации, 8.51%
|
|
|
Drug Delivery
4 публикации, 8.51%
|
|
|
Gels
3 публикации, 6.38%
|
|
|
Journal of Pharmaceutical Sciences
3 публикации, 6.38%
|
|
|
International Journal of Pharmaceutics
3 публикации, 6.38%
|
|
|
Pharmaceutics
2 публикации, 4.26%
|
|
|
Separation and Purification Technology
2 публикации, 4.26%
|
|
|
Journal of Liposome Research
2 публикации, 4.26%
|
|
|
Drug Development and Industrial Pharmacy
2 публикации, 4.26%
|
|
|
International Journal of Polymeric Materials and Polymeric Biomaterials
2 публикации, 4.26%
|
|
|
Russian Chemical Reviews
1 публикация, 2.13%
|
|
|
Nanomaterials
1 публикация, 2.13%
|
|
|
BioNanoScience
1 публикация, 2.13%
|
|
|
International Journal of Nanomedicine
1 публикация, 2.13%
|
|
|
Journal of Pharmacy and Pharmacology
1 публикация, 2.13%
|
|
|
BioMed Research International
1 публикация, 2.13%
|
|
|
Frontiers in Pharmacology
1 публикация, 2.13%
|
|
|
Frontiers in Microbiology
1 публикация, 2.13%
|
|
|
International Journal of Biological Macromolecules
1 публикация, 2.13%
|
|
|
Drug Delivery and Translational Research
1 публикация, 2.13%
|
|
|
Renal Failure
1 публикация, 2.13%
|
|
|
Cureus
1 публикация, 2.13%
|
|
|
Journal of Pharmaceutical Innovation
1 публикация, 2.13%
|
|
|
OpenNano
1 публикация, 2.13%
|
|
|
1
2
3
4
|
Издатели
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
16 публикаций, 34.04%
|
|
|
Taylor & Francis
12 публикаций, 25.53%
|
|
|
Springer Nature
8 публикаций, 17.02%
|
|
|
MDPI
6 публикаций, 12.77%
|
|
|
Frontiers Media S.A.
2 публикации, 4.26%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.13%
|
|
|
Wiley
1 публикация, 2.13%
|
|
|
Hindawi Limited
1 публикация, 2.13%
|
|
|
2
4
6
8
10
12
14
16
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
47
Всего цитирований:
47
Цитирований c 2025:
4
(8.51%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Abdelbary A. et al. Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride // Pharmaceutical Development and Technology. 2016. Vol. 22. No. 3. pp. 409-417.
ГОСТ со всеми авторами (до 50)
Скопировать
Abdelbary A., Salem H. F., Khallaf R. A., Ali A. M. A. Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride // Pharmaceutical Development and Technology. 2016. Vol. 22. No. 3. pp. 409-417.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1080/10837450.2016.1219916
UR - https://doi.org/10.1080/10837450.2016.1219916
TI - Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride
T2 - Pharmaceutical Development and Technology
AU - Abdelbary, Ahmed
AU - Salem, Heba F.
AU - Khallaf, Rasha A
AU - Ali, Ahmed M A
PY - 2016
DA - 2016/08/31
PB - Taylor & Francis
SP - 409-417
IS - 3
VL - 22
PMID - 27476543
SN - 1083-7450
SN - 1097-9867
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2016_Abdelbary,
author = {Ahmed Abdelbary and Heba F. Salem and Rasha A Khallaf and Ahmed M A Ali},
title = {Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride},
journal = {Pharmaceutical Development and Technology},
year = {2016},
volume = {22},
publisher = {Taylor & Francis},
month = {aug},
url = {https://doi.org/10.1080/10837450.2016.1219916},
number = {3},
pages = {409--417},
doi = {10.1080/10837450.2016.1219916}
}
Цитировать
MLA
Скопировать
Abdelbary, Ahmed, et al. “Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride.” Pharmaceutical Development and Technology, vol. 22, no. 3, Aug. 2016, pp. 409-417. https://doi.org/10.1080/10837450.2016.1219916.
Ошибка в публикации?